Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

5-oxoETE triggers nociception in constipation-predominant irritable bowel syndrome through MAS-related G protein-coupled receptor D.

Bautzova T, Hockley JRF, Perez-Berezo T, Pujo J, Tranter MM, Desormeaux C, Barbaro MR, Basso L, Le Faouder P, Rolland C, Malapert P, Moqrich A, Eutamene H, Denadai-Souza A, Vergnolle N, Smith ESJ, Hughes DI, Barbara G, Dietrich G, Bulmer DC, Cenac N.

Sci Signal. 2018 Dec 18;11(561). pii: eaal2171. doi: 10.1126/scisignal.aal2171.

2.

Protease-activated receptor 1 is implicated in irritable bowel syndrome mediators-induced signaling to thoracic human sensory neurons.

Desormeaux C, Bautzova T, Garcia-Caraballo S, Rolland C, Barbaro MR, Brierley SM, Barbara G, Vergnolle N, Cenac N.

Pain. 2018 Jul;159(7):1257-1267. doi: 10.1097/j.pain.0000000000001208.

PMID:
29554016
3.

Galanin enhances systemic glucose metabolism through enteric Nitric Oxide Synthase-expressed neurons.

Abot A, Lucas A, Bautzova T, Bessac A, Fournel A, Le-Gonidec S, Valet P, Moro C, Cani PD, Knauf C.

Mol Metab. 2018 Apr;10:100-108. doi: 10.1016/j.molmet.2018.01.020. Epub 2018 Jan 31.

4.

Central chronic apelin infusion decreases energy expenditure and thermogenesis in mice.

Drougard A, Fournel A, Marlin A, Meunier E, Abot A, Bautzova T, Duparc T, Louche K, Batut A, Lucas A, Le-Gonidec S, Lesage J, Fioramonti X, Moro C, Valet P, Cani PD, Knauf C.

Sci Rep. 2016 Aug 23;6:31849. doi: 10.1038/srep31849.

5.

Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients With Irritable Bowel Syndrome.

Cenac N, Bautzova T, Le Faouder P, Veldhuis NA, Poole DP, Rolland C, Bertrand J, Liedtke W, Dubourdeau M, Bertrand-Michel J, Zecchi L, Stanghellini V, Bunnett NW, Barbara G, Vergnolle N.

Gastroenterology. 2015 Aug;149(2):433-44.e7. doi: 10.1053/j.gastro.2015.04.011. Epub 2015 Apr 22.

PMID:
25911511
6.

Bioadhesive pellets increase local 5-aminosalicylic acid concentration in experimental colitis.

Bautzová T, Rabišková M, Béduneau A, Pellequer Y, Lamprecht A.

Eur J Pharm Biopharm. 2012 Jun;81(2):379-85. doi: 10.1016/j.ejpb.2012.02.011. Epub 2012 Feb 22.

PMID:
22386911
7.

Coated chitosan pellets containing rutin intended for the treatment of inflammatory bowel disease: in vitro characteristics and in vivo evaluation.

Rabišková M, Bautzová T, Gajdziok J, Dvořáčková K, Lamprecht A, Pellequer Y, Spilková J.

Int J Pharm. 2012 Jan 17;422(1-2):151-9. doi: 10.1016/j.ijpharm.2011.10.045. Epub 2011 Nov 3.

PMID:
22079717
8.

Multiparticulate systems containing 5-aminosalicylic acid for the treatment of inflammatory bowel disease.

Bautzová T, Rabišková M, Lamprecht A.

Drug Dev Ind Pharm. 2011 Sep;37(9):1100-9. doi: 10.3109/03639045.2011.560156. Epub 2011 Mar 21. Review.

PMID:
21417610

Supplemental Content

Loading ...
Support Center